Free Trial
NASDAQ:BIOA

BioAge Labs (BIOA) Stock Price, News & Analysis

BioAge Labs logo
$4.93 +0.13 (+2.71%)
As of 08/29/2025 04:00 PM Eastern

About BioAge Labs Stock (NASDAQ:BIOA)

Key Stats

Today's Range
$4.79
$5.10
50-Day Range
$4.12
$4.93
52-Week Range
$2.88
$26.62
Volume
166,433 shs
Average Volume
89,341 shs
Market Capitalization
$176.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BIOA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioAge Labs and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BIOA Stock News Headlines

BioAge Labs to Present at Upcoming Investor Conferences
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.tc pixel
BioAge Labs, Inc. (BIOA) Gets a Hold from William Blair
BioAge Labs (BIOA) Q2 Revenue Hits $2.4M
See More Headlines

BIOA Stock Analysis - Frequently Asked Questions

BioAge Labs' stock was trading at $4.20 at the start of the year. Since then, BIOA shares have increased by 17.4% and is now trading at $4.93.

BioAge Labs, Inc. (NASDAQ:BIOA) released its quarterly earnings results on Wednesday, August, 6th. The company reported ($0.60) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.56) by $0.04.

BioAge Labs (BIOA) raised $198 million in an initial public offering on Thursday, September 26th 2024. The company issued 11,000,000 shares at a price of $18.00 per share.

BioAge Labs' top institutional shareholders include Geode Capital Management LLC (1.26%), Marshall Wace LLP (0.63%), Stonepine Capital Management LLC (0.42%) and Bridgeway Capital Management LLC (0.15%).

Shares of BIOA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/06/2025
Today
8/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BIOA
CIK
1709941
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$71.11 million
Net Margins
N/A
Pretax Margin
-2,045.74%
Return on Equity
-25.39%
Return on Assets
-23.22%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
13.21
Quick Ratio
13.21

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$8.22 per share
Price / Book
0.60

Miscellaneous

Outstanding Shares
35,850,000
Free Float
28,386,000
Market Cap
$176.74 million
Optionable
N/A
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:BIOA) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners